As President Joe Biden wraps up his term, his administration is proposing that Medicare and Medicaid cover popular weight loss medications. The new rule would dramatically expand access to anti-obesity drugs like Wegovy, Ozempic and Mounjaro.
Media Landscape
See who else is reporting on this story and which side of the political spectrum they lean. To read other sources, click on the plus signs below. Learn more about this data
Left 27%
Center 67%
Right 6%
Bias Distribution Powered by Ground News™
As of now, Medicare and Medicaid only cover these drugs if they’re prescribed to treat certain conditions like diabetes. This new proposal could provide coverage for patients looking to use them exclusively for weight loss.
Download the SAN app today to stay up-to-date with Unbiased. Straight Facts™.
Point phone camera here
The change would dramatically reduce out-of-pocket costs for the drugs, which can cost more than $1,000 for a month’s supply, according to the White House. The CDC estimates more than 40% of Americans are considered obese and could benefit from these drugs.
The new rule would expand access to the drugs for 3.4 million Americans who use Medicare and another 4 million people enrolled in Medicaid, White House officials said.
Tags: Health Care, Joe Biden, CDC, Health, Medicaid, Medicare, White House, Ozempic, Centers for Disease Control and Prevention, Weight Loss, Insurance
AS PRESIDENT JOE BIDEN WRAPS UP HIS TERM – HIS ADMINISTRATION IS PROPOSING FOR MEDICARE AND MEDICAID TO COVER POPULAR WEIGHT LOSS MEDICATIONS.
THE NEW RULE WOULD DRAMATICALLY EXPAND ACCESS TO ANTI-OBESITY DRUGS LIKE WEGOVY, OZEMPIC AND MOUNJARO.
AS OF NOW – MEDICARE AND MEDICAID ONLY COVER THESE DRUGS IF THEY‘RE PRESCRIBED TO TREAT CERTAIN CONDITIONS LIKE DIABETES… BUT THIS NEW PROPOSAL COULD PROVIDE COVERAGE FOR PATIENTS LOOKING TO USE THEM EXCLUSIVELY FOR WEIGHT LOSS.
THE CHANGE WOULD DRAMATICALLY REDUCE OUT-OF-POCKET COSTS FOR THE DRUGS – WHICH CAN COST MORE THAN A THOUSAND DOLLARS FOR A MONTH’S SUPPLY, ACCORDING TO THE WHITE HOUSE.
ACCORDING TO THE C-D-C – MORE THAN 40 PERCENT OF AMERICANS ARE CONSIDERED OBESE AND **COULD** BENEFIT FROM THESE DRUGS.
THE NEW RULE WOULD EXPAND ACCESS TO THE DRUGS FOR 3 POINT 4 MILLION AMERICANS WHO USE MEDICARE AND ANOTHER 4 MILLION PEOPLE ENROLLED IN MEDICAID, WHITE HOUSE OFFICIALS SAID.
Media Landscape
See who else is reporting on this story and which side of the political spectrum they lean. To read other sources, click on the plus signs below. Learn more about this data
Left 27%
Center 67%
Right 6%
Bias Distribution
132 other sources covering this story
Total News Sources
132
Leaning Left
24
Center
60
Leaning Right
5
Last Updated
6 hours ago
Bias Distribution Powered by Ground News™
Straight to your inbox.
By entering your email, you agree to the Terms & Conditions and acknowledge the Privacy Policy.
